Hypoxia-inducible Factor Prolyl Hydroxylase Inhibitors on Sarcopenia in Hemodialysis Patients

NCT07162090 · clinicaltrials.gov ↗

PHASE4

Phase

NOT_YET_RECRUITING

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Sarcopenia
Anemia Associated With Chronic Kidney Disease (CKD)
Dialysis Patients

Interventions

DRUG: Roxadustat
DRUG: Recombinant human erythropoietin (EPO)

Sponsor

Tianjin Medical University General Hospital